U.S. Markets closed

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
12.13+0.08 (+0.66%)
At close: 4:00PM EDT
People also watch
GNVCCRISIMMUBCRXLJPC
  • K
    Kinky
    Kinky
    300 Million! ! \some moron posts stupid and the weasels follow, IPLEX! when all else fails! post about a drug that hasn't been mfg for 9 years Is not being trialed\Insmed has NO APPROVED iplex indication because the drug is no longer valid ( mfg expired). min of 2-3 years would be needed to get the new manufactured drug FDA approval\but they dont know this \Who would post Lies about this company pretending to have a drug iplex?\idiotinvestor village
  • Z
    Zorro
    Zorro
    2nd quarter numbers =Increased Positions 67 4,889,844
    Decreased Positions 41 2,934,744
    Held Positions 17 51,177,882
    Total Institutional Shares 125 59,002,470
    I agree this was all before the attack
  • P
    Predict
    Predict
    So does retail lose and the big time money make a fortune?Are those free options 10x more valuable then any stock management may own? Are they willing to take a cheap takeover price to a large pharma? If the results were reported tomorrow would the stock shoot up 50% to $18? Biotech has scrwd me again
  • l
    linda
    linda
    Anyone have any buys by the top Institutions SINCE June 30? Why haven't they added?
  • P
    Predict
    Predict
    June 30th data .The second quarter had buyers in the $17 to $18 dollar range.The sellers came 2 months later. what changed?Listen to Insmeds last presentation.W.Lewis and every one in management couched their comments in caution IF hope etc. I dont buy conspiracy theories.
  • K
    Kinky
    Kinky
    The poor idiotvillage investors don't get why Sales jobs are not hires\ THEY ARE CONTINGENT ON GETTING AN APPROVED DRUG TO SELL \hopefully by eoy 2018
  • F
    Fghyujk Sdfghj
    Fghyujk Sdfghj
    Traders had fun yesterday with "President Trump to visit Insmed headquarters!
    With the Trump golf course close by and Trumps current residence in Bridgewater N.J a great photo opp and a great chance to unload every single share
  • J
    Joe West
    Joe West
    It's not Manipulation! There are definite sellers.
    INSM top Institutional holder sold 5 % of their holdings on Friday in one day.A lot of second quarter sellers also
    Looks to be setting up for a not so great result JMHO I hope not I own too much
  • A
    Ashley
    Ashley
    In the short-term INSM does not seem to be like a good trade. Ive been struggling with this stock lately. Some of my other trades have been from awe-some*sto-cks which are working out pretty well.
  • K
    Kinky
    Kinky
    Register your complaint with the SEC today! LOL for what? !\ investorvillage squirrels
  • J
    Jennifer
    Jennifer
    My guess is that INSM is due for a pullback in the short-run. awe-some*sto-cks just allerted a new stock - it beats having to dig online yourself for new stock ideas.
  • l
    linda
    linda
    So today is a good day?Volume seems to be drying up but are they finished?Painful for longs.Some mention of 2nd Quarter activity but that was 6 weeks ago+ $17.25 -18. Are the biggest owners of Insmed planning a dilution down here again? A placement could be done to only "strategic owners" {2/3rds owed by just 6 funds}
  • t
    tom
    tom
    Linda is a loser. Will have to turn to hooking!
  • K
    Kinky
    Kinky
    $11.54 please
  • K
    Kinky
    Kinky
    Why do all analst recc the price that I sold at 2 years ago and then went short to the price we are at now? \Coincidence?\ I think not
  • Z
    Zorro
    Zorro
    So its a plot if there is a big seller who thinks the trials may be bad and is dumping?
    There is a seller and the shares are real IV is full of idiots Stop posting about them
  • K
    Kinky
    Kinky
    Google Linhaliq +NTM \which is the better short term trade for a double?\ INSM or ARDM \after a sell on the news ARDM is up 40% in the last 2 weeks
  • K
    Kinky
    Kinky
    ARDM -FDA GIVES OK TO FILE AFTER REVIEWING THEIR PHASE3 TRIAL UP 18% INVESTORS PILING IN announced it has submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Linhaliq™ for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) patients with chronic lung infections with Pseudomonas aeruginosa (P. aeruginosa).
  • l
    linda
    linda
    Aradigm is not a direct competitor and their market may come under the umbrella of respiratory treatments.The FDA it appears found Aradigm to be quite convincing.Based on Arardigms NTM patent and FDA discussions =if successful with Pulmaquin [inhaled ciprofloxacin} non-cystic fibrosis bronchiectasis (BE). Aradigm who already has spoken to investors about CF may be Insmeds worst dream[NTM] .Give them their due =Aradigm is one of those bios that emerges from the ashes of biotech failures We shall see how they do but short term could be a pretty good investment
  • Z
    Zorro
    Zorro
    at least we didnt wake up to down $2 dollars.Institutional holdings ( of 6 weeks ago) showed an increase overall but in the next 6 weeks someone or 3 were selling
    nervous